| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2023 | BSX Boston Scientific Corp | Monson Jonathan | SVP, Global Controller And CAO | Sell | 5,000 | $50.00 | $250,000.00 | -12.5% | +6.5% | +36.1% | |
| Mar 31, 2023 | BFLY Butterfly Network, Inc. | Stoica Andrei G53 | Chief Technology Officer | Sell | 1,200 | $1.65 | $1,980.00 | -0.1% | +22.9% | -44.7% | |
| Mar 31, 2023 | BSX Boston Scientific Corp | Sorenson John Bradley55 | EVP, Global Operations | Sell | 4,000 | $50.00 | $200,000.00 | -10.4% | +6.5% | +36.1% | |
| Mar 31, 2023 | COO Cooper Companies, Inc. | Ricupati Agostino62 | SVP &CAO | Sell | 1,000 | $370.00 | $370,000.00 | -53.7% | +1.8% | +6.3% | |
| Mar 31, 2023 | TMCI Treace Medical Concepts, Inc. | Mott Richard W81 | Director | Sell | 133,498 | $25.54 | $3,410,027.05 | -6.4% | -2.1% | -50.4% | |
| Mar 30, 2023 | TMCI Treace Medical Concepts, Inc. | Treace James T53 | Director | Sell | 50,000 | $25.86 | $1,293,170.00 | -5.2% | -5.4% | -49.3% | |
| Mar 30, 2023 | BSX Boston Scientific Corp | Mirviss Jeffrey B.45 | EVP&Pres, Periph Intervent | Sell | 4,903 | $49.60 | $243,188.80 | -5.5% | +7.8% | +38.1% | |
| Mar 30, 2023 | LIVN Livanova Plc | McDonald Damien60 | CEO | Sell | 2,220 | $42.55 | $94,461.00 | -1.9% | +19.6% | +31.0% | |
| Mar 30, 2023 | XAIR Beyond Air, Inc. | Carey Robert | Director | Buy | 20,000 | $6.38 | $127,500.00 | +1.1% | -29.1% | -73.5% | |
| Mar 29, 2023 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 741 | $20.62 | $15,279.42 | -0.3% | +10.0% | -11.0% | |
| Mar 29, 2023 | MXCT Maxcyte, Inc. | Douglas Richard | Director | Buy | 80,000 | $4.32 | $345,480.00 | +400.0% | +0.5% | -5.0% | |
| Mar 29, 2023 | BLFS Biolife Solutions Inc | Foster Karen A.68 | Chief Quality Officer | Sell | 390 | $20.62 | $8,041.80 | -0.3% | +10.0% | -11.0% | |
| Mar 29, 2023 | BLFS Biolife Solutions Inc | Rice Michael72 | CEO | Sell | 936 | $20.62 | $19,300.32 | -0.2% | +10.0% | -11.0% | |
| Mar 29, 2023 | BLFS Biolife Solutions Inc | Berard Todd67 | Chief Marketing Officer | Sell | 521 | $20.62 | $10,743.02 | -0.4% | +10.0% | -11.0% | |
| Mar 29, 2023 | PEN Penumbra Inc | Grewal Harpreet60 | Director | Sell | 875 | $271.00 | $237,125.00 | -8.3% | +19.1% | -18.8% | |
| Mar 29, 2023 | IRTC Irhythm Holdings, Inc. | Wilson Daniel G.63 | EVP, Corp Dev Inv Rel | Sell | 4,000 | $125.00 | $500,000.00 | -10.2% | -20.9% | -4.9% | |
| Mar 29, 2023 | DCTH Delcath Systems, Inc. | Michel Gerard J47 | Chief Executive Officer | Buy | 19,646 | $4.84 | $95,086.64 | +11.1% | +9.4% | -13.9% | |
| Mar 29, 2023 | TMCI Treace Medical Concepts, Inc. | Bays F Barry80 | Director | Sell | 58,698 | $25.16 | $1,477,074.86 | -2.3% | -6.4% | -48.9% | |
| Mar 28, 2023 | XAIR Beyond Air, Inc. | Lee Yoori | Director | Buy | 3,115 | $6.34 | $19,749.10 | +32.7% | -28.1% | -72.3% | |
| Mar 28, 2023 | RBOT Vicarious Surgical Inc. | Liang Philip45 | Director | Buy | 74,300 | $2.32 | $172,227.40 | +11.9% | -21.7% | -87.3% | |
| Mar 27, 2023 | DXR Daxor Corp | Michel Robert J61 | Chief Financial Officer | Buy | 4,750 | $0.00 | - | +46.1% | -13.7% | -23.2% | |
| Mar 27, 2023 | SONX Sonendo, Inc. | Chen Roy T | Chief Talent Officer | Sell | 2,505 | $1.81 | $4,542.57 | -0.8% | - | - | |
| Mar 27, 2023 | SONX Sonendo, Inc. | Kirkpatrick Andrew J | Chief Operating Officer | Sell | 4,163 | $1.81 | $7,549.18 | -2.3% | - | - | |
| Mar 27, 2023 | SONX Sonendo, Inc. | Smith Michael John | Chief Commercial Officer | Sell | 6,928 | $1.81 | $12,563.24 | -0.9% | - | - | |
| Mar 27, 2023 | SONX Sonendo, Inc. | Watts Michael Patrick | Chief Financial Officer | Sell | 4,710 | $1.81 | $8,541.11 | -0.8% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.